Table 1.
Characteristics of patients and odds ratio (OR) of CAM usage due to various factors.
| Variables | All | CAM Users | CAM Non-Users | OR of CAM Usage | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N = 732 | (%) | N = 342 | (%) | N = 380 | (%) | p * | OR | (95% CI) | p ** | OR | (95% CI) | p *** | ||
| Age median (IQR) | 62 (55–68) | 61 (54–67) | 63 (56–69) | 0.009 | 0.99 | (0.97–1.00) | 0.02 | 0.99 | (0.98–1.00) | 0.07 | ||||
| Gender | ||||||||||||||
| Female | 407 | (55.6) | 199 | (58.2) | 200 | (52.6) | 0.13 | 1.00 | Reference | |||||
| Male | 325 | (44.4) | 143 | (41.8) | 180 | (47.4) | 1.25 | (0.93–1.68) | 0.13 | |||||
| Education | ||||||||||||||
| Primary | 48 | (6.6) | 18 | (5.3) | 30 | (7.9) | 0.04 | 1.00 | Reference | 1.00 | Reference | |||
| Vocational | 194 | (26.5) | 76 | (22.2) | 112 | (29.5) | 1.13 | (0.59–2.17) | 0.71 | 1.01 | (0.52–1.97) | 0.97 | ||
| Secondary | 304 | (41.5) | 153 | (44.7) | 147 | (38.7) | 1.73 | (0.93–3.25) | 0.08 | 1.47 | (0.78–2.80) | 0.24 | ||
| Higher | 186 | (25.4) | 95 | (27.8) | 91 | (23.9) | 1.74 | (0.91–3.34) | 0.10 | 1.49 | (0.76–2.91) | 0.25 | ||
| Place of residence | ||||||||||||||
| Village | 113 | (15.4) | 61 | (17.8) | 50 | (13.2) | 0.17 | 1.00 | Reference | 1.00 | Reference | |||
| City < 50,000 inhabitants | 145 | (19.8) | 67 | (19.6) | 75 | (19.7) | 0.73 | (0.44–1.21) | 0.22 | 0.72 | (0.43–1.19) | 0.20 | ||
| City 50–200,000 inhabitants | 310 | (42.4) | 133 | (38.9) | 174 | (45.8) | 0.63 | (0.40–0.97) | 0.04 | 0.64 | (0.41–1.00) | 0.05 | ||
| City >200,000 inhabitants | 164 | (22.4) | 81 | (23.7) | 81 | (21.3) | 0.82 | (0.50–1.33) | 0.42 | 0.84 | (0.51–1.38) | 0.49 | ||
| Professional activity | ||||||||||||||
| Employed | 299 | (40.9) | 164 | (48.0) | 130 | (34.2) | <0.001 | 1.00 | Reference | |||||
| Pensioner | 424 | (57.9) | 175 | (51.1) | 244 | (64.2) | 2.52 | (0.62–10.28) | 0.20 | |||||
| Unemployed | 9 | (1.2) | 3 | (0.9) | 6 | (1.6) | 1.43 | (0.35–5.81) | 0.61 | |||||
| Cancer localization | ||||||||||||||
| Colon | 170 | (23.2) | 80 | (23.4) | 90 | (23.7) | 1.00 | (0.37–2.72) | 1.00 | |||||
| Upper digestive system | 113 | (15.5) | 46 | (13.5) | 64 | (16.8) | 0.38 | 0.81 | (0.29–2.25) | 0.68 | ||||
| Lung | 89 | (12.2) | 49 | (14.3) | 39 | (10.3) | 1.41 | (0.50–4.00) | 0.51 | |||||
| Breast | 89 | (12.2) | 49 | (14.3) | 38 | (10.0) | 1.45 | (0.51–4.11) | 0.48 | |||||
| Gynecological | 64 | (8.7) | 29 | (8.5) | 31 | (8.2) | 1.05 | (0.36–3.09) | 0.93 | |||||
| Head and neck | 42 | (5.7) | 21 | (6.1) | 21 | (5.5) | 1.13 | (0.36–3.48) | 0.84 | |||||
| Urinary system—without prostate | 37 | (5.1) | 16 | (4.7) | 21 | (5.5) | 0.86 | (0.27–2.72) | 0.79 | |||||
| Brain | 31 | (4.2) | 12 | (3.5) | 19 | (5.0) | 0.71 | (0.21–2.35) | 0.58 | |||||
| Prostate | 17 | (2.3) | 8 | (2.3) | 9 | (2.4) | 1.00 | Reference | ||||||
| Other | 80 | (10.9) | 32 | (9.4) | 48 | (12.6) | 0.75 | (0.26–2.15) | 0.59 | |||||
| Time since diagnosis (years) median (IQR) | 0.62 (0.33–1.54) | 0.70 (0.41–1.71) | 0.53 (0.28–1.44) | 0.002 | 1.00 | (0.99–1.00) | 0.13 | |||||||
| Intention of planned treatment | ||||||||||||||
| Curative | 370 | (50.6) | 171 | (50.0) | 196 | (51.6) | 0.83 | 1.00 | Reference | |||||
| Palliative | 167 | (22.8) | 81 | (23.7) | 83 | (21.8) | 1.12 | (0.77–1.62) | 0.55 | |||||
| Difficult to evaluate | 195 | (26.6) | 90 | (26.3) | 101 | (26.6) | 1.02 | (0.72–1.45) | 0.91 | |||||
| Stage of disease | ||||||||||||||
| Early | 163 | (22.3) | 62 | (18.1) | 101 | (26.6) | 0.02 | 1.00 | Reference | 1.00 | Reference | |||
| Local and/or regional development | 238 | (32.5) | 120 | (35.1) | 111 | (29.2) | 1.76 | (1.17–2.65) | 0.006 | 1.69 | (1.12–2.56) | 0.01 | ||
| Metastatic | 194 | (26.5) | 101 | (29.5) | 92 | (24.2) | 1.79 | (1.17–2.73) | 0.007 | 1.69 | (1.10–2.60) | 0.02 | ||
| Difficult to evaluate | 137 | (18.7) | 59 | (17.3) | 76 | (20.0) | 1.26 | (0.79–2.01) | 0.32 | 1.25 | (0.78–2.01) | 0.35 | ||
IQR—interquartile range; OR—odds ratio; CI—confidence interval; * p-value estimated using chi-square test; ** p-value estimated using univariate logistic regression model; *** p-value estimated using multivariate logistic regression model.